Although risk factors for first stroke have been identified, the predictors of long-term stroke recurrence are less well understood. We performed the present study to determine whether dementia diagnosed three months after stroke onset is a n independent risk factor for long-term stroke recurrence. Methods: We examined 242 patients (age = 72.0 js 8.7 years) hospitalized with acute ischemic stroke who had survived the first three months without recurrence and followed them to identify predictors of long-term stroke recurrence. We diagnosed dementia three months after stroke using modified DSM-111-R criteria based on neuropsychological and functional assessments. The effects of conventional stroke risk factors and dementia status on survival free of recurrence were estimated using Kaplan-Meier analyses, and the relative risks (RR) of recurrence were calculated using Cox proportional hazards models. Results: Dementia (RR = 2.71, 95% CI = 1.36 to 5.42); cardiac disease (RR = 2.18, CI = 1.15 to 4.12); and sex, with women at higher risk (RR = 2.03, CI = 1.01 to 4.10), were significant independent predictors of recurrence, while education (RR = 1.90, CI = 0.77 to 4.68), admission systolic blood pressure >160 mm Hg (RR = 1.80, CI = 0.94 to 3.44) and alcohol intake exceeding 160 grams per week (RR = 1.86, CI = 0.79 to 4.38) were weakly related. Conclusions: Our results suggest that dementia significantly increases the risk of long-term stroke recurrence, with additional independent contributions by cardiac disease and sex. Cognitive impairment may be a surrogate marker for multiple vascular risk factors and larger infarct volume that may serve to increase the risk of recurrence. Alternatively, less aggressive medical management of stroke patients with cognitive impairment or noncompliance of such patients with medical therapy may be bases for an increased rate of stroke recurrence.
of long-term stroke recurrence following cerebral infarction. The Framingham Study1 reported a fiveyear stroke recurrence rate of 42 percent while the Stroke Data Bank2 reported a two-year rate of 14 percent. Recent community-based studies have reported five-year recurrence rates ranging from 25 to 30 p e r~e n t .~,~ In contrast to stroke incidence rates,5 stroke recurrence rates have not declined, 6 and with increasing numbers of stroke survivors, there is a significant need to identify the predictors of recurrence. While few risk factors for stroke recurrence have been consistently identified, it is likely some of them will differ from the recognized risk factors for first stroke. Identification of patient groups at increased risk of stroke recurrence may permit targeted application of secondary prevention measures to reduce recurrence rates.
While the prevalence7 and incidences,9 of dementia following stroke are high and survival is significantly reduced among stroke patients with dementia,lo the prognostic implications of cognitive impairment after stroke with regard to the risk of stroke recurrence have not been investigated. Thus, we performed the present study to determine whether dementia diagnosed three months after ischemic stroke onset would be an independent risk factor for longterm stroke recurrence.
Methods.
Subjects. Subjects for this study were recruited among patients consecutively admitted within 30 days of onset of ischemic stroke to Columbia-Presbyterian Medical Center. Eligible patients were 60 years of age or older, spoke English or Spanish as a primary language, and had a diagnosis of acute ischemic stroke of any type. Index ischemic stroke was defined as the acute onset of a focal neurologic deficit attributable to vascular disease of the brain and supported by CT scan (normal or relevant infarct) performed within one week of symptom onset. Patients with mild to moderate degrees of aphasia were included, but those with severe aphasia were excluded if they scored <2 on the severity rating scale of the Boston Diagnostic Aphasia Examination (BDAE)." Additional exclusions were the presence of a concomitant primary neurologic disorder potentially affecting cerebral function (e.g., Parkinson's disease), primary language other than English or Spanish, or severe medical comorbidity (e.g., terminal cancer) limiting survival over the planned follow-up period of five years. Informed consent was obtained from subjects or their family members using procedures approved by the Institutional Review Board of Columbia-Presbyterian Medical Center.
During hospitalization, medical and neurologic histories were collected and each patient underwent structured neurologic examinations, cognitive assessment using the MiniMental State Examination (MMSE),IZ and functional assessments using the Barthel Index13 and the Blessed Functional Activity Scale (BFAS).I4 A more extensive description of our recruitment procedures is available in an earlier publication on methods and baseline finding^.^ Among the 297 patients who were initially enrolled, 251 received assessments that were adequate for the determination of dementia status three months after stroke, while 9 of those 251 patients were excluded due to early recurrence (i.e., less than 90 days from the index stroke), leaving 242 patients eligible for this study. The mean age of these subjects was 72.0 2 8.7 years and their mean education was 10.1 ? 4.6 years. Males comprised 47.1% of the sample and the cohort was of mixed race-ethnicity with 38.8% black, 34.7% white, and 26.5% Hispanic patients.
Three months after the onset of stroke, subjects were administered a battery of neuropsychological tests developed for the purpose of diagnosing dementia in a bilingual (English and Spanish), multiethnic, elderly population,15J6 and the neurologic and functional examinations were repeated. We chose an interval of three months following stroke onset for neuropsychological testing to allow sufficient time for patients to exhibit a n essentially stable c o~r s e .~~J~ Based on all available information gathered from the neurologic, neuropsychological, and functional assessments administered at the three month visit, dementia was diagnosed using modified DSM-111-R criteria.lg We required the presence of memory impairment as well as deficits in at least two other cognitive domains (i.e., orientation, abstract reasoning, language, and visuospatial function), combined with functional impairment unrelated to physical deficits, as documented with the BFAS. The requirement that patients exhibit deficits in memory and at least two other cognitive domains was intended to ensure that patients were not misclassified on the basis of poor performance on any single measure. To diagnose dementia in aphasic patients who were testable, impairment in nonverbal memory was required. Impairment within each cognitive domain was defined by performance on neuropsychological tests falling below predetermined cutoff scores for each of the subtests developed from pilot data. 15 The use of cutoff scores was intended to ensure that study criteria for the diagnosis of dementia would be objective and replicable. We have reported norms for this battery in our stroke and control subjects and consider the cutoffs to be conservative. 16 Agreement on the diagnosis of dementia was excellent, with a Kappa of 0.96 based on independent judgments by two raters in a sample of 63 patients. Based on these operationalized criteria, 62 of the 242 patients (25.6%) were found to be demented a t the three month examination. The Clinical Dementia RatingZo was determined for each patient as a measure of dementia severity.
We used historical information obtained from the BFAS, administered a t 7 to 10 days after the index stroke,
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1318 NEUROLOGY 48 May 1997 to reflect the functional status of our patients in the twelve months preceding the stroke and to determine the major clinical subtypes of dementia. When there was evidence of functional deficits predating the index stroke, we diagnosed "mixed" dementia (Alzheimer's disease [AD] and stroke). In the absence of pre-existing functional problems, cerebrovascular disease was inferred to be the central mechanism for the dementia syndrome and a diagnosis of vascular dementia (VaD) was made.
The definition of stroke recurrence was similar to that of the index stroke, but we additionally required that the neurologic deficit be clearly different from that of the index stroke, involve a different anatomic site or vascular territory from that of the index stroke, or be of a stroke subtype different from that of the index stroke.2 Based on combined clinical, laboratory, and neuroimaging information, the stroke mechanism for each recurrent event was determined using methods modified from the Stroke Data Bank.21 Both ischemic and hemorrhagic strokes were included as recurrent cerebrovascular events. Exact dates for all stroke recurrences were recorded and for those patients who had more than one stroke recurrence we used the date of the first recurrence.
Patients were re-examined annually with the clinical assessments described above. Scheduling of annual examinations was based on the date of index stroke onset. We performed continuous surveillance using the methods described above to identify cases of stroke recurrence. To maximize follow-up rates, we made visits to the subject's homes or health care facilities if they were unable or unwilling to visit the medical center, and we did not consider them as having refused any interval examination until a t least four attempts had been made to contact and examine them. We also relied upon a daily survey of admissions to the medical center, information from six month interval telephone follow-up calls, and, in cases of death, review of medical records and death certificates to screen for stroke recurrence. Whenever possible, patients were examined and brain imaging was obtained at the time of the recurrence to support the diagnosis of recurrent stroke. Each patient was followed up until death or June 30, 1993 , the end of the prospective study period.
We used survival curves obtained by the Kaplan-Meier product-limit methodz2 to estimate the proportion of patients free of recurrence in the overall sample and then in groups stratified by dementia status and other potential predictors. These included demographic variables (i.e., age, education, sex, and race); conventional vascular risk factors (i.e., hypertension; diabetes; cardiac disease, with myocardial infarction, angina, congestive heart failure, valvular heart disease, and atrial fibrillation combined into one variable; hypercholesterolemia; and cigarette smoking, defined as history of smoking at least one cigarette per day for at least one year); clinical features of the index stroke (stroke syndrome classified as major hemispheral versus other, reflecting the range and severity of neurologic deficits; vascular territory classified as internal carotid versus vertebrobasilar; stroke subtype classified as large artery atherosclerosis, lacunar, cardiogenic embolism, or cryptogenic, based on all available diagnostic information from the index stroke evaluation;21 and the Barthel Index score received 7 to 10 days after the index stroke as a measure of functional impairment); blood Stroke recurrence.
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Statistical methods.
pressure readings on admission; and selected laboratory data (i.e., blood glucose on admission and cholesterol level determined 7 to 10 days after stroke).
We chose to include patients with a history of prior stroke or TIA in our analyses because previous studies have identified both prior stroke and TIA as predictors of r e c u r r e n~e~.~~ and we wished to examine their role in our sample. In addition, a history of prior stroke is frequently present in hospitalized stroke patients2z3 and we sought a sample that would be representative of elderly stroke patients to increase the generalization of our findings. Finally, silent or asymptomatic cerebral infarction is frequently found on brain imaging even when patients have no history of clinically evident ~t r o k e ,~~.~~ and exclusion of such patients from studies of stroke recurrence would severely reduce the pool of eligible subjects.
To investigate the putative J-or U-shaped association between alcohol use and stroke risk,26,27 alcohol consumption was assessed as part of a structured questionnaire focusing on general medical risk factors, diet, and lifestyle. The amount and category (beer, spirits, wine) of alcohol typically consumed during one week was converted into grams of alcohol, with one standard drink (a can of beer, a glass of wine, or a single measure of spirits) representing the equivalent of 10 grams of Consumption was classified as >160 grams and 60 to 160 grams versus <60 grams per week.
The cumulative proportions of patients experiencing a stroke recurrence over the follow-up period were determined in groups stratified by the above variables. Survival time was calculated from the date of the three-month examination and statistical significance was determined by the log-rank test. Reasons for censoring included death unrelated to stroke recurrence, subject drop-out, and reaching the end of the study period. The crude incidence rate (IR) of stroke recurrence, stratified by the presence of dementia, was calculated using life-table methods. To estimate the relative risk of stroke recurrence associated with the presence of dementia while adjusting for demographic variables and other potentially relevant factors, we fitted Cox proportional hazards models.28 Variables were selected for entry into the model based on univariate results ( p 5 0.1) or a priori hypotheses based on previously published studies.
Results. Uniuariate analyses. Among the 242 patients, 208 (86%) completed at least one visit after the baseline examination, 176 (72.7%) completed at least two visits, 111 (45.9%) completed at least three visits, and 31 (12.8%) completed at least four visits. Deaths unrelated to stroke recurrence occurred in 67 patients (27.7%) and only 5 patients (2.1%) were lost to any follow-up. Thus, we were able to obtain information on stroke recurrence in the vast majority of patients with our surveillance methods. Median follow-up for the cohort was 34.5 months, with a maximum follow-up of 59 months. Excluding deaths occurring before each planned follow-up interval, the proportion of patients examined among those at risk of stroke recurrence was 93.8% at year 1, 91.3% at year 2, 96.6% at year 3, and 94.6% at year 4. During 647 person-years of followup, 45 patients had a recurrent stroke, resulting in a cumulative stroke recurrence rate of 24.0% and an unadjusted IR of 7.0 per 100 person-years. Cumulative stroke recurrence rates stratified by demographic variables, dementia status, vascular risk factors, laboratory data, and clinical features of the index stroke are presented in table 1.
Among the demographic variables, we found no effect for age and race but sex did exert a significant influence on the rate of recurrence, with women at elevated risk. Education was of borderline significance, with less educated patients at elevated risk. Dementia was a significant predictor of stroke recurrence, with almost 50% of demented patients having a recurrent stroke during the follow-up period of 59 months compared to 20% of the nondemented group. The unadjusted IR of stroke recurrence in the demented group was 12 per 100 person-years, compared to an IR of 6.0 per 100 person-years in the nondemented group. The cumulative proportion of patients surviving free of recurrence stratified by dementia status is presented graphically in the figure. By the log rank test, survival curves for the two groups were significantly different (x2 = 6 . 7 6 ,~ = 0.009).
Among vascular risk factors, there was a trend towards a higher rate of recurrence in patients with cardiac disease. Although a history of smoking was associated with a lower rate of recurrence, further analysis revealed a confounding association between smoking and age, with smokers tending to die at a younger age and thus not at risk of stroke recurrence. There was a trend towards a higher rate of stroke recurrence in patients with an admission systolic blood pressure (SBP) > 160 mm Hg, but a significant effect was not found for an elevated diastolic blood pressure (DBP). Laboratory data and clinical features of the index stroke, including stroke severity, stroke syndrome, vascular territory, and stroke subtype, did not have a significant effect on the stroke recurrence rate. A history of clinically evident prior stroke or TIA failed to significantly affect the stroke recurrence rate.
The initial Cox model included demographic variables alone, with sex and education showing trends towards significance. Women and patients with less than 12 years of education were at higher risk of stroke recurrence in this model. When baseline dementia status was added to this basic demographic model, we identified a significant independent effect of dementia on the risk of recurrence, with an RR of 2.08 (95% CI = 1.09 to 3.99). Age and race were not significant factors in this model. Sex and education retained their borderline effects, with women and patients with less than 12 years of education having elevated risks of recurrence (RR = 1.75, 95% CI = 0.91 to 3.40, and RR = 1.92, CI = 0.78 to 4.70 respectively).
The final model was developed by adding other variables based on improvement in the log-likelihood ratio, as shown in table 2. The Cox analysis including these variables resulted in an RR of 2.71 (95% CI = 1.36 to 5.42) for dementia as an independent predictor of stroke recurrence. Cardiac disease (RR = 2.18, 95% CI = 1.15 to 4.12) was also a significant predictor of stroke recurrence, as was sex, with women at higher risk (RR = 2.03, 95% CI = 1.01 to 4.10). In an effort to determine the specific cardiac diagnoses associated with an increased risk of stroke recurrence, we examined individual cardiac conditions in the Cox proportional hazards analysis, but we found no single cardiac condition was an independent predictor of stroke recurrence, probably due to small sample sizes in those Multivariate analyses. Blood glucose level was measured on admission while cholesterol level was measured 7 to 10 days after index stroke. Some recurrence rates are based on an incomplete sample due to missing data. TIA = transient ischemic attack SBP = systolic blood pressure; DBP = diastolic blood pressure. . We included alcohol consumption in the multivariate analysis after univariate testing revealed an association between gender and alcohol use and its inclusion improved the log-likelihood ratio of the model. Light to moderate drinking (60 to 160 grams per week) was not inversely associated with stroke recurrence (RR = 0.90, 95% CI = 0.32 to 2.49), while heavy drinking (>160 grams per week) showed a trend towards significance for a n elevated risk (RR = 1.86, 95% CI = 0.79 to 4.38). Given that we found dementia to be a significant independent predictor of stroke recurrence, we also examined the relationship between the severity of dementia and the magnitude of risk of stroke recurrence. In a Cox analysis, we found that moderate to severe dementia (corresponding to CDR scores of 2 2 ) was a significant independent predictor of stroke recurrence (RR = 3.03, 95% CI = 1.33 to 6.91), while mild dementia (corresponding to a CDR score of 1) was weakly related (RR = 1.58, 95% CI = 0.70 to 3.57) after adjusting for demographic variables. Additionally, prior stroke, when considered separately from TIA, was not a significant variable either in our univariate or multivariate analyses and did not significantly alter the calculated relative risks of the predictors when forced into our final multivariate model.
Discussion.
Previous studies of outcome after cerebral infarction have tended to focus on survival after stroke, rather than stroke r e c~r r e n c e ,~~-~~ while those which have investigated predictors of recurrence have tended to limit their analysis to conventional vascular risk fa~tors.'-~Jj Although previous studies have examined the effects of stroke-related cognitive impairment on functional recovery and survival and suggested that stroke survivors with cognitive deficits have a poorer prognosis with regard to those our study is the first, to our knowledge, to examine the role of cognitive impairment after stroke as a predictor of long-term recur-rence. Recurrent stroke was frequent in our sample, with an overall five-year cumulative stroke recurrence rate of 24.0%, which is comparable to that of other s t~d i e s .~,~ We found in our prospective investigation that the incidence of stroke recurrence was approximately doubled among patients with dementia following stroke relative t o nondemented patients. Dementia after stroke remained a significant independent risk factor for long-term stroke recurrence after adjusting for demographic variables and other vascular risk factors. We found no effect for race or age on the risk of stroke recurrence, but women and patients with fewer years of education were at higher risk of recurrent stroke in our sample. With regard to vascular risk factors, only cardiac disease was an independent predictor of long-term stroke recurrence, although a trend towards increasing risk was noted for a systolic blood pressure (SBP) >160 mm Hg. In addition, we noted a weak trend towards an elevated risk of stroke recurrence for heavy alcohol consumption but no significant protective effect for light to moderate alcohol consumption.
Our finding that dementia is an independent predictor of long-term stroke recurrence is intriguing and could be related t o a number of pathogenic mechanisms. First, since stroke itself increases the risk of dementia,7-9 and our findings suggest that dementia may also cause stroke, a bidirectional causal link between dementia and stroke may exist, with dementia serving as a surrogate marker for larger infarct volume or multiple vascular risk factors, and, thus, an increased stroke risk. Indirect support for this hypothesis is derived from several sources, including the observations that larger infarct volumes may be associated with dementia after ischemic s t r~k e~~,~~ and that the risk of dementia in stroke populations may be increased by exposure to vascular risk factors such as prior symptomatic stroke, myocardial infarction, and diabetes melli-US.^^,^^ Data from a recently conducted, populationbased, prospective cohort study provides further evidence in support of a bidirectional causal link between cognitive impairment and cerebrovascular disease in the elderly, having found that a low score on a mental status questionnaire was an independent risk factor for stroke incidence in initially stroke-free subjects aged 71 years and older.40 Interestingly, the association between cognitive impairment and the risk of a future stroke was independent of the significant effects of hypertension and diabetes. The authors proposed that silent or subclinical cerebrovascular disease may be an underrecognized but important risk factor for cognitive impairment in the elderly and may serve to increase the risk of clinically evident stroke.
Second, the reported association between strokerelated dementia and the presence on CT of prior asymptomatic or silent brain infarcts offers a potential mechanism underlying higher rates of recurrence in demented stroke patients. Among 163 patients with silent brain infarction in the Stroke Data
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Bank, dementia was more frequent with increasing number and size of silent lesions,41 while in the Stroke and Aging Research Project, we have found multiple lacunar infarcts, both symptomatic and asymptomatic, to be a significant correlate of dementia following ischemic
The European Atrial Fibrillation Trial (EAFT) reported that patients with silent infarcts on brain CT had a higher risk for both recurrent vascular events in general (vascular death, myocardial infarction, systemic embolism, and stroke) and for recurrent stroke in ~a r t i c u l a r .~~ Other studies have found the extent of cerebral white matter disease or leukoaraiosis on CT in stroke patients to be an independent risk factor for recurrent stroke and associated with an increased frequency of dementia.44,45 Silent brain infarcts and leukoaraiosis may increase susceptibility to strokerelated cognitive decline by reducing cognitive reserve, may be significantly more prevalent in patients with dementia following stroke, and may serve as a marker for a greater burden of cerebral arteriosclerosis, thereby placing these patients at higher risk of recurrent stroke.
Third, dementia may be a predictor of long-term stroke recurrence due to less aggressive medical management of patients with stroke-related cognitive deficits. Diminished intellectual competence following stroke may result in patients being considered poor candidates for secondary prevention programs. Physicians may be reluctant to initiate oral anticoagulation with warfarin, for example, due to the elevated risk of hemorrhage that may result from inadequate monitoring and inconsistent administration in stroke patients with significant cognitive deficits. Alternatively, noncompliance of demented stroke patients with prescribed secondary preventive measures due to cognitive impairment may be a basis for an increased rate of stroke recurrence. In addition, patients with cognitive impairment following stroke are significantly more likely to have functional deficits resulting in nursing home placement or dependent living at home,16 potentially compromising medical follow-up and management of hypertension, diabetes, and other chronic vascular risk factors.
We also found cardiac disease to be a significant independent risk factor for long-term stroke recurrence. To represent cardiac disease, we used a variable combining a broad range of cardiac conditions that could cause cardiogenic embolic cerebral infarction.46,47 Small sample sizes in our subgroup analyses probably hindered our ability to detect effects for individual cardiac diseases. M a r q u a r d~e n~~ found in a retrospective study that congestive heart failure, atrial fibrillation, and electrocardiographic abnormalities were associated with higher rates of recurrence, while in the Stroke Data Bank an abnormal first electrocardiogram was a significant risk factor for stroke recurrence at one year. 48 The Framingham Study1 reported that cardiac conditions such as coronary heart disease and congestive heart failure contributed significantly t o higher five-year cumulative recurrence rates, while investigators in the Lehigh Valley Stroke Studyz3 found an approximately eightfold increased risk of recurrent stroke among patients with myocardial infarction and a pooled grouping of other cardiac diseases. The recent availability of transesophageal echocardiography has added new data in support of an increased risk of recurrent stroke with potential cardiac sources of embolism, such as patent foramen ovale with inter-atrial shunt, left atrial thrombus, and atrial septa1 aneurysm, and suggests that further studies are needed to determine the optimal management of stroke patients with potential cardiac sources of e m b o l i~m .~~~~*
The role of hypertension in relation to stroke recurrence is unclear with previous studies reporting conflicting r e s u l t~.~-~,~ We found no effect for hypertension diagnosed prior to the index stroke nor for an elevated DBP on admission, but we noted that an admission SBP >160 mm Hg increased the risk of long-term stroke recurrence. Irie et al. 51 reported that patients with a poststroke SBP of 150 mm Hg or greater had a significantly higher stroke recurrence rate than those with poststroke SBP below 150 mm Hg. Although not specifically assessed in our patients, isolated systolic hypertension (ISH) is common in the elderly,52 and 36-year follow-up data from the Framingham Study has shown stroke incidence to be significantly greater in elderly patients with ISH. 53 The Systolic Hypertension in the Elderly Program (SHEP) has provided further support for a critical role of ISH in stroke, with its finding that stepped-care antihypertensive drug treatment of ISH in patients >60 years of age significantly reduced the five-year incidence of stroke. 54 The stronger effect of SBP compared to DBP in predicting recurrent stroke in our sample parallels its disproportionate effect in the prediction of stroke ocurrence and stroke-related m~r t a l i t y .~~,~~,~~ In case-control studies, heavy alcohol intake has been reported to be an independent risk factor for both hemorrhagic and ischemic ~t r o k e .~~,~~ Heavy alcohol use was reported to be an independent risk factor for stroke recurrence within 5 years of index stroke in the Northern Manhattan Stroke Study.3 Several epidemiologic studies have suggested a J-shaped relationship between alcohol consumption and initial ischemic stroke, with low to moderate levels of alcohol intake having a protective effect against the occurrence of stroke and heavy intake elevating the risk of a cerebrovascular event.26z27, 57 We were unable to confirm a J-shaped association between alcohol consumption and the risk of recurrent stroke in our sample. Alcohol intake exceeding 160 grams per week did result in an increased risk of stroke recurrence but low to moderate levels of alcohol consumption (60 to 160 grams per week) were not associated with a protective effect. While our data showed that 29 of 157 nondrinkers (18.5%) and 5 of 35 light to moderate drinkers (14.3%) experienced a recurrence over the follow-up period versus 10 of 48 heavy drinkers (20.8%), suggesting a possible protective effect in the light to moderate drinking group, small sample sizes in the light to moderate and heavy drinking groups may have hampered our ability t o recognize significant effects. Our reliance on self-reports of alcohol intake may also have resulted in an underestimation of the true effect of heavy alcohol use in relation to the risk of stroke recurrence.
Although they were treated primarily as covariates in our study, the effects of sex and education on stroke recurrence deserve further comment. We found sex to be a significant independent predictor of stroke recurrence, with women at elevated risk. Of the previous studies of factors influencing the risk of recurrent ~t r~k e ,~-~,~,~~.~~~~~,~ only the Framingham study1 reported an effect for gender, with men having almost double the rate of recurrence observed in women. Substantial differences in study design and patient type in previous studies of stroke recurrence make meaningful comparisons between studies diffcult. In our sample, further subanalyses revealed sex differences in the distribution of age and alcohol intake, with women tending to be older and men tending to be heavier drinkers, suggesting that an unequal distribution of stroke risk factors between the sexes may account for the higher rate of recurrence that we observed in women. This interesting finding needs further study to determine whether identified vascular risk factors interzct with gender to influence stroke recurrence. Although we did not have the necessary data in our sample, age at menopause and estrogen status59 are additional factors that may affect stroke recurrence in women and warrant investigation in future studies. Education was of borderline significance in our multivariate analyses, with less educated patients experiencing a higher rate of recurrence. The effect of education on stroke recurrence has not been previously examined and our finding may reflect poorer control of risk factors in the less educated patients. After a first stroke, patients with less education may not be aware of the substantial risk of recurrent stroke, with resultant failure to modify diet or risk behaviors such as smoking and alcohol use. Among the less educated, lower socioeconomic status with resultant reduced access to regular health care may also affect control of vascular risk factors and may be an explanation for their increased susceptibility to stroke recurrence.
The limitations of our study include an inability to investigate infarct volume, silent brain infarction, and leukoaraiosis as predictors of recurrence due to a lack of quantitative neuroimaging, as well as a restricted sample size which limited our ability to reliably investigate the association between the clinical subtype of dementia (e.g., AD with stroke, VaD) and risk of stroke recurrence. Although we might infer that patients with VaD would be at greater risk of stroke recurrence than those with mixed dementia due to a greater burden of cerebrovascular disease, our results suggest that the dementia syndrome it-self would be likely to remain an important determinant of recurrent stroke, independent of presumed etiology, because dementia remained a significant independent predictor of stroke recurrence when we explored risk factors for cerebrovascular disease and characteristics of the index stroke in our multivariate models. We also lacked reliable information on compliance with prescribed therapies and medical follow-up in our sample. We plan to continue to follow our original cohort, and we are recruiting a second cohort to expand our observations regarding dementia and recurrent stroke, including the relationship between apolipoprotein E genotype and risk of stroke recurrence. Further prospective studies of stroke patients are warranted to investigate the role of silent stroke, larger infarct volumes, and cerebral white matter disease as predictors of stroke recurrence and how they contribute to the pathogenesis of stroke-related cognitive decline.
We found that dementia following stroke is a potent risk factor for recurrent stroke, suggesting that careful attention should be paid to the detection of cognitive impairment in stroke patients. The recognition of dementia in stroke survivors may identify a subgroup at higher risk for recurrence, providing an opportunity for targeted intervention. For example, the institution of supervised treatment programs for stroke survivors with dementia may lower rates of stroke recurrence in this group. Our results also support prompt evaluation and treatment of cardiac disease in stroke survivors to prevent recurrent stroke due to cardiogenic cerebral embolism. Education of stroke patients and their families, in particular those who are less educated or from lower socioeconomic strata, may increase their awareness of risk factors for stroke recurrence, encourage the modification of risk-prone behaviors, and improve compliance with medical therapies, leading to a better outcome following ischemic stroke.
